Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Non Operating Income (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Non Operating Income for 3 consecutive years, with -$27.5 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 3743.44% to -$27.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$27.1 million through Dec 2025, down 2886.71% year-over-year, with the annual reading at -$27.8 million for FY2025, 2247.11% down from the prior year.
  • Non Operating Income hit -$27.5 million in Q4 2025 for Camp4 Therapeutics, down from -$71000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $755000.0 in Q4 2024 to a low of -$27.5 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$2.5 million across 3 years, with a median of $251000.0 in 2024.
  • Biggest YoY gain for Non Operating Income was 404.14% in 2025; the steepest drop was 3743.44% in 2025.
  • Year by year, Non Operating Income stood at $486000.0 in 2023, then surged by 55.35% to $755000.0 in 2024, then crashed by 3743.44% to -$27.5 million in 2025.
  • Business Quant data shows Non Operating Income for CAMP at -$27.5 million in Q4 2025, -$71000.0 in Q3 2025, and $441000.0 in Q2 2025.